AESOMED is a global leading anti-aging innovation company built on the first-in-class recombinant exosome technology.
Founded in 2023, AESOMED has been developing innovative and clinical-proven medical aesthetic products to prevent and revert signs of aging.
Combining patented recombinant exosomes with our 313rd formulation, we created signature anti-aging product: FORMULA 313.
We have cGMP-certified manufacturing in China and US. We distribute brand products and high-quality customized active ingredients across countries.
THE NEXT CHAPTER OF REGENERATION.
Company Details
- Employees
- 3
- Founded
- -
- Industry
- Medical Equipment Manufacturing
- NAICS
-
Medical Equipment and Supplies ManufacturingSurgical and Medical Instrument ManufacturingSurgical Appliance and Supplies ManufacturingDental Equipment and Supplies ManufacturingOphthalmic Goods ManufacturingDental Laboratories
- Website
- http://www.aesomed.com
- Keywords
- Exosome and Anti-aging.
Aesomed Questions
Aesomed's website is http://www.aesomed.com
Aesomed's LinkedIn profile is https://www.linkedin.com/company/aesomed
Aesomed has
3 employees.
View email and phone details for 3
employees at Aesomed.
Aesomed's industry is
Medical Equipment Manufacturing
Aesomed's top competitors are
Prospect Advisors,
Createai,
Optima Ai Solutions,
Twin Peaks Capital,
Yum! China Holding Inc,
Biotrack Capital,
Trendy International Group,
Nedes Estimating Company,
晨壹基金 Firstlight Capital,
The Longreach Group.
Aesomed's categories are Medical Equipment Manufacturing
Aesomed's founding year is 2023
